Propanc Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Propanc Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Propanc Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 688M shares, a 4538% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 688M +673M +4538% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 479M +473M +7839% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 110M -2.51B -95.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 36.2M -1.21B -97.1% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 14.8M -662M -97.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 6.03M +5.81M +2637% Jun 30, 2023 10-K 2024-09-30
Q1 2023 2.62B +2.54B +2983% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.25B +1.19B +2248% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 677M +633M +1445% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 220K -13.8M -98.4% Jun 30, 2022 10-K 2023-09-28
Q1 2022 85M +80.1M +1611% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 53.1M +51.6M +3567% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 43.8M -672M -93.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 14.1M +13.8M +5345% Jun 30, 2021 10-K 2022-09-28
Q1 2021 4.97M -13.5M -73.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 1.45M -788K -35.3% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 716M +714M +61066% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 258K -710K -73.3% Jun 30, 2020 10-K 2021-09-28
Q1 2020 18.5M -367M -95.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 2.23M -271M -99.2% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 1.17M -174M -99.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 968K +875K Jun 30, 2019 10-K 2020-10-01
Q1 2019 385M +354M +1140% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 273M +256M +1447% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 176M +169M +2540% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 92.8K* -4.46M Jun 30, 2018 10-K 2019-10-15
Q1 2018 31.1M +27.3M +730% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 17.7M -850M -98% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 6.65M -787M -99.2% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 4.55M +1.64M +56.2% Jun 30, 2017 10-K 2018-09-17
Q1 2017 3.74M -599M -99.4% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 867M +435M +100% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 794M +446M +129% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 2.91M -345M -99.2% Jun 30, 2016 10-K 2017-09-28
Q1 2016 602M +270M +81% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 433M +302M +231% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 347M +265M +320% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 347M +275M +378% Jun 30, 2015 10-K 2016-09-28
Q1 2015 333M +260M +358% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 131M +58.1M +79.9% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 82.8M +11M +15.3% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 72.7M +2.05M +2.91% Jun 30, 2014 10-K 2015-09-30
Q1 2014 72.7M +2.05M +2.91% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 72.7M -136K -0.19% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 71.8M -876K -1.21% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 70.6M -2.07M -2.85% Jun 30, 2013 10-K 2014-10-14
Q1 2013 70.6M -1.52M -2.11% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 72.8M +817K +1.14% Dec 31, 2012 10-Q 2013-02-20
Q3 2012 72.7M Sep 30, 2012 10-Q 2012-11-19
Q2 2012 72.7M +790K +1.1% Jun 30, 2012 10-K 2013-10-15
Q1 2012 72.2M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 72M Dec 31, 2011 10-Q/A 2012-03-07
Q2 2011 71.9M Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.